(a) Specifications.
Each tablet contains 50 or 150 milligrams (mg) masitinib mesylate.
(b) Sponsor.
See No. 052913 in § 510.600(c) of this chapter.
(c) Conditions of use in dogs—
(1) Amount.
12.5 mg/kilograms (5.7 mg/lb) of body weight daily.
(2) Indications for use.
For the treatment of recurrent (post-surgery) or nonresectable Grade II or III cutaneous mast cell tumors in dogs that have not previously received radiotherapy and/or chemotherapy except corticosteroids.
(3) Limitations.
Federal law restricts this drug to use by or on the order of a licensed veterinarian. It is a violation of Federal law to use this product other than as directed in the labeling.
Code of Federal Regulations
[76 FR 6327, Feb. 4, 2011]